Image: Panel discussion, pictured from LEFT:
Researcher Ruby Hamilton, Prof Andrew Perkins,
Dr Cecily Forsyth, A/Prof David Ross, Dr Ashlyn Chee,
Dr Zi Ng and Michelle Nelson (MPN AA)
What does optimal diagnosis and management of MPNs look like in 2025?
The MPN AA is delighted to advise that videos and presentations from this fabulous symposium are now available.
The MPN AA thanks our wonderful speakers for generously providing their time and energy.
The topics covered at the symposium were:
| Session | Presenter |
|---|---|
| Session 1 | |
| What is an MPN in 2025? MPN symptoms and blood count control. |
Prof Andrew Perkins |
| MPNs and thrombosis MPNs and other health risk factors (video starts at 35:36) |
Dr Cecily Forsyth |
| Session 2 | |
| Understanding blood tests, bone marrow morphology, and why and when BMBs are needed | Prof Wendy Erber |
| MPN Gene Panel (video starts at 33:26) |
Dr Xuan Ni Tan |
| Session 3 | |
| What’s new in ET & PV treatment? | Dr Zi Ng |
| What’s new in MF treatment? (video starts at 24:46) |
Dr Ashlyn Chee |
| New ways to assess treatment response / clinical trial endpoints (video starts at 54:29) |
A/Prof David Ross |
| Session 4 | |
| Mutational burden monitoring | Dr Zi Ng |
| Joint Presentation – Developing new blood tests/biomarkers for leukaemic and fibrotic progression (video starts at 16:26) |
Dr Belinda Guo & Ruby Hamilton |
| Are we ready to disease modify in MPN? (video starts at 40:50) |
Prof Claire Harrison |
| Panel Q&A (video starts at 1:03:19) |
Clinicians MPN AA |
Videos and presentations are available HERE.
